Skip to main content
Journal cover image

Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ.

Publication ,  Journal Article
Meyerson, AF; Lessing, JN; Itakura, K; Hylton, NM; Wolverton, DE; Joe, BN; Esserman, LJ; Hwang, ES
Published in: Breast
December 2011

INTRODUCTION: An option for active surveillance is not currently offered to patients with ductal carcinoma in situ (DCIS); however a small number of women decline standard surgical treatment for noninvasive cancer. The purpose of this study was to assess outcomes in a cohort of 14 well-informed women who elected non-surgical active surveillance with endocrine treatment alone for estrogen receptor-positive DCIS. METHODS: Retrospective review of 14 women, 12 of whom were enrolled in an IRB-approved single-arm study of 3 months of neoadjuvant endocrine therapy prior to definitive surgical management. The patients in this report withdrew from the parent study opting instead for active surveillance with endocrine treatment and imaging. RESULTS: 8 women had surgery at a median follow up of 28.3 months (range 10.1-70 months), 5 had stage I IDC at surgical excision, and 3 had DCIS alone. 6 women remain on surveillance without evidence of invasive disease for a median of 31.8 months (range 11.8-80.8 months). CONCLUSION: Long-term active surveillance for DCIS is feasible in a well-informed patient population, but is associated with risk of invasive cancer at surgical excision.

Duke Scholars

Published In

Breast

DOI

EISSN

1532-3080

Publication Date

December 2011

Volume

20

Issue

6

Start / End Page

529 / 533

Location

Netherlands

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Receptors, Estrogen
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Middle Aged
  • Humans
  • Follow-Up Studies
  • Female
  • Combined Modality Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Meyerson, A. F., Lessing, J. N., Itakura, K., Hylton, N. M., Wolverton, D. E., Joe, B. N., … Hwang, E. S. (2011). Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Breast, 20(6), 529–533. https://doi.org/10.1016/j.breast.2011.06.001
Meyerson, Anna F., Juan N. Lessing, Kaoru Itakura, Nola M. Hylton, Dulcy E. Wolverton, Bonnie N. Joe, Laura J. Esserman, and E Shelley Hwang. “Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ.Breast 20, no. 6 (December 2011): 529–33. https://doi.org/10.1016/j.breast.2011.06.001.
Meyerson AF, Lessing JN, Itakura K, Hylton NM, Wolverton DE, Joe BN, et al. Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Breast. 2011 Dec;20(6):529–33.
Meyerson, Anna F., et al. “Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ.Breast, vol. 20, no. 6, Dec. 2011, pp. 529–33. Pubmed, doi:10.1016/j.breast.2011.06.001.
Meyerson AF, Lessing JN, Itakura K, Hylton NM, Wolverton DE, Joe BN, Esserman LJ, Hwang ES. Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Breast. 2011 Dec;20(6):529–533.
Journal cover image

Published In

Breast

DOI

EISSN

1532-3080

Publication Date

December 2011

Volume

20

Issue

6

Start / End Page

529 / 533

Location

Netherlands

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Receptors, Estrogen
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Middle Aged
  • Humans
  • Follow-Up Studies
  • Female
  • Combined Modality Therapy